fashion -WSS

fashion

author：entertainment 2025-10-01 20:12:17 - browse：27968

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： FDA warns J&J's Abiomed: We will regulate your software

hotspot

WSS

Hospital price transparency does save money, advocate argues

Latest bird flu infection made farmworker sicker than earlier cases

Health insurers say they are turning to AI to cut costs, improve care

iTeos Therapeutics debuts first data on TIGIT

Studies point to risks of excluding people with obesity from drug trials

FDA warns J&J's Abiomed: We will regulate your software

focus

fashion

hotspot

In age of alternative facts, a scholarly course on calling out crap

Insmed lung disease drug hits target in key Phase 3 trial

DIEP, the 'gold standard' of breast reconstruction, is under threat

Prosthetic arm enables patients to feel the objects they grip

Medical leaders decry Supreme Court decision on affirmative action

Researchers explore possible ties between long Covid, menopause

At least 13 dead in Texas as scorching temps continue

STAT Summit: Biotech founders on deal

As demand for Covid shots wanes, Moderna seeks its next success

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

hotspot

FDA gives detailed accounting of AI

First Opinion Podcast: What happens when kids become caregivers?

The explosion of genetic testing requires a new approach

Solve the antibiotic resistance crisis with preventive drugs

Hospital price transparency does save money, advocate argues

Beam Therapeutics to lay off 20% of its staff, re

leisure time

focus

hotspot

leisure time